Skip to main content
. 2019 Mar 15;9(3):e024159. doi: 10.1136/bmjopen-2018-024159

Figure 2.

Figure 2

(A) Barriers to the adoption of high value practices (low molecular weight heparin for venous thromboembolism prophylaxis) by professional group. (B) Barriers to the de-adoption of low value practices (albumin for fluid resuscitation) by professional group. ICU, intensive care unit; NP, nurse practitioner.